Nathaniel Barry, Eng-Siew Koh, Martin A Ebert, Alisha Moore, Roslyn J Francis, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Sweet P Ng, Michael Back, Benjamin Chua, Mark B Pinkham, Andrew Pullar, Claire Phillips, Joseph Sia, Peter Gorayski, Hien Le, Suki Gill, Jeremy Croker, Nicholas Bucknell, Catherine Bettington, Farhan Syed, Kylie Jung, Joe Chang, Andrej Bece, Catherine Clark, Mori Wada, Olivia Cook, Angela Whitehead, Alana Rossi, Andrew Grose, Andrew M Scott
BACKGROUND AND PURPOSE: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility in Radiation Oncologist (RO) derivation of standard-of-care target volumes (TVMR ) and hybrid target volumes (TVMR+FET ) incorporating pre-defined FET PET biological tumour volumes (BTVs). MATERIALS AND METHODS: Central review and analysis of TVMR and TVMR+FET was undertaken across three benchmarking cases...
April 2024: Physics and Imaging in Radiation Oncology